Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

87.00
-0.1700-0.20%
Volume:535.80K
Turnover:46.22M
Market Cap:3.02B
PE:-19.20
High:88.10
Open:85.47
Low:85.26
Close:87.17
52wk High:95.95
52wk Low:30.82
Shares:34.77M
Float Shares:28.68M
Volume Ratio:5.50
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5319
EPS(LYR):-3.9613
ROE:-26.36%
ROA:-17.95%
PB:4.92
PE(LYR):-21.96

Loading ...

Disc Medicine submits NDA to FDA for bitopertin in patients with EPP

TIPRANKS
·
Sep 30

Disc Medicine Submits NDA to FDA for Bitopertin in Erythropoietic Protoporphyria; Seeks Accelerated and Priority Review

Reuters
·
Sep 30

Disc Medicine Inc - Seeks Accelerated Approval and Priority Review for Bitopertin

THOMSON REUTERS
·
Sep 30

Disc Medicine Announces Submission of New Drug Application (Nda) to US FDA for Accelerated Approval of Bitopertin for Patients With Erythropoietic Protoporphyria (Epp)

THOMSON REUTERS
·
Sep 30

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - CASH DIVIDEND FOR THE THIRD QUARTER OF 2025 - $0.40 PER COMMON SHARE

Dow Jones
·
Sep 10

Disc Medicine Inc. Unveils New Corporate Presentation on Targeting Red Blood Cell Biology and Hematologic Disorders

Reuters
·
Sep 03

Disc Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 27

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Aug 27

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

THOMSON REUTERS
·
Aug 26

Shattuck Labs Inc - Proceeds Expected to Fund Operations Into 2029

THOMSON REUTERS
·
Aug 26

Rapid7, Residio Tech, and 4 More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Aug 23

Disc Medicine Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 18

Director Kevin Bitterman Reports Disposal of Common Shares of Disc Medicine Inc

Reuters
·
Aug 16

Director Kevin Bitterman Reports Disposal of Common Shares in Disc Medicine Inc

Reuters
·
Aug 08

Disc Medicine Shares Fall After Wider-Than-Expected Q2 Loss

MT Newswires Live
·
Aug 07

Earnings Flash (IRON) Disc Medicine Posts Q2 Net Loss $1.58 a Share, vs. FactSet Est of $1.13 Loss

MT Newswires Live
·
Aug 07

Disc Medicine Inc. Announces Initiation of Phase 2 Study for DISC-3405 in Polycythemia Vera with Initial Data Expected in 2026

Reuters
·
Aug 07

Disc Medicine Q2 EPS $(1.58) Misses $(1.13) Estimate

Benzinga
·
Aug 07

Disc Medicine Inc - Expects Initial Data From From Phase 2 Study of Disc-0974 in Q4 2025

THOMSON REUTERS
·
Aug 07

Disc Medicine Inc - on Track to Submit Nda for Bitopertin in October 2025

THOMSON REUTERS
·
Aug 07